Can a new airway device make surgery safer?
NCT ID NCT02531256
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This trial evaluates a new laryngeal mask airway device, called the LMA Protector, for managing breathing during surgery. It will involve 40 adults undergoing elective gynecological procedures where an LMA is indicated. Researchers will measure how easily the device can be inserted and how well it seals the airway, aiming to see if it offers advantages over current options.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- LMA Protector, a new laryngeal mask airway device used to manage breathing during surgery
- What this could lead to
- If successful, this device could offer a more reliable and safer way to manage airways during surgery, reducing complications and improving patient outcomes.
- What could go wrong
- This is a small, early-stage study with only 40 participants, so results may not apply to all patients. The device may not perform better than existing airway devices, and there are inherent risks like sore throat or injury.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Start date
-
Jan 2014
- Finished
-
Dec 2015
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 70 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * planned elective surgery with indication for LMA use Exclusion Criteria: * body mass index of 30 or more, known gastro-oesophageal reflux, patients with increased risk of aspiration, upper airway pathology and mouth opening of less than 2 cm
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Airway morbidity are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
KK Women's and Children's Hospital
Singapore, 229899, Singapore
More trials for these conditions
Other studies related to the condition(s) this trial covers.